TrialPloS one2023

Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group.

Umesh G Lalloo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.